完成了AskBio的第二阶段心力衰竭基因治疗试验. AskBio completes enrollment for Phase 2 heart failure gene therapy trial.

亚斯克生物宣布完成了AB-1002的第二期临床试验,该基因疗法旨在治疗心力衰竭. AskBio announced the completion of enrollment in a Phase 2 clinical trial for AB-1002, an investigational gene therapy designed to treat heart failure.